Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3455)	12/29/1997 7:46:00 PM
From: Izzy	Read Replies (2) \| Respond to of 6136

It's called "sour grapes"!!

To: Izzy who wrote (3455)	12/30/1997 12:04:00 PM
From: Oliver & Co	Read Replies (1) \| Respond to of 6136

I would like the mango blintzes. In a Medical Economics article about 3 years ago, they showed that when you compared on an hourly rate several professions, doctors made less per hour than accountants, and lawyers. And this has been getting worse. I think that AGPH may come back up after the begining of the year, at least I hope. Do they have guava blintzes? if they do send some over to John W.

To: Izzy who wrote (3455)	12/30/1997 12:05:00 PM
From: Oliver & Co	Respond to of 6136

"Clinton to Seek More Money to Help Pay for AIDS Drugs" New York Times (12/30/97) P. A14; Pear, Robert ÿÿÿÿ White House officials announced that President Clinton has decided to seek significant increase in federal spending for HIV treatments, including a 35 percent increase in spending for AIDS drug-assistance programs. Officials report that Clinton will ask for at least $385 million for such programs in the next fiscal year, up from $285 million this year and $167 in 1996. According to federal health officials, the decision reflects the administration's recent willingness to address the concerns of advocacy groups that focus on AIDS and gay rights. Although the additional money is greatly needed, Daniel Zingale, the executive director of advocacy group AIDS Actio, noted: "The AIDS drug-assistance program is not a long-term solution and is not a substitute for changes in Medicaid eligibility. It provides the drugs, but not the basic health care and services that must accompany the drugs to make them effective."